Frequency and prognosis of HER2-low status in Mexican patients with metastatic breast cancer

被引：1
|
作者：
Martinez-Cannon, Bertha Alejandra
Verduzco-Aguirre, Haydee Cristina
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P3-05-58
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-05-58
引用
收藏
页数：3
相关论文
共 50 条
  • [41] HER2-low breast cancer: where are we?
    Molinelli, Chiara
    Jacobs, Flavia
    Marchio, Caterina
    Pitto, Francesca
    Cosso, Maurizio
    Spinaci, Stefano
    de Azambuja, Evandro
    Schettini, Francesco
    Agostinetto, Elisa
    Lambertini, Matteo
    BREAST CARE, 2022, 17 (06) : 533 - 544
  • [42] Epidemiology of HER2-low breast cancer in Lithuania
    Cesas, A.
    Poskiene, L.
    Valkiuniene, R. B.
    Radvinskiene, L.
    Lege, I.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 103 - 104
  • [43] HER2-Low Breast Cancer: a New Subtype?
    Corti, Chiara
    Giugliano, Federica
    Nicolo, Eleonora
    Tarantino, Paolo
    Criscitiello, Carmen
    Curigliano, Giuseppe
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (05) : 468 - 478
  • [44] HER2-Low Breast Cancer: Now and in the Future
    Kang, Sora
    Kim, Sung-Bae
    CANCER RESEARCH AND TREATMENT, 2024, 56 (03): : 700 - 720
  • [45] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
    de Moura Leite, Luciana
    Cesca, Marcelle Goldner
    Tavares, Monique Celeste
    Santana, Debora Maciel
    Saldanha, Erick Figueiredo
    Guimaraes, Paula Tavares
    Sa, Daniella Dias Silva
    Simoes, Maria Fernanda Evangelista
    Viana, Rafael Lima
    Rocha, Francisca Giselle
    Loose, Simone Klog
    Silva, Sinara Figueiredo
    Pirolli, Rafaela
    Fogassa, Camilla Albina Zanco
    Mattos, Bruna Raphaeli Silva
    Campos, Fernando Augusto Batista
    Sanches, Solange Moraes
    de Lima, Vladmir Claudio Cordeiro
    Ponde, Noam Falbel
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 190 (01) : 155 - 163
  • [46] HER2-Low Expression in Metastatic Breast Cancer: Discordance in Patients with both Cytology and Surgical Pathology Specimens
    Glasgow, Akisha
    VanderLaan, Paul
    Collins, Laura
    Quintana, Liza
    LABORATORY INVESTIGATION, 2023, 103 (03) : S302 - S303
  • [47] Impressive improvements in survival for patients with HER2-low metastatic breast cancer-establishing a new subgroup?
    Pervan, M.
    Princk, H.
    Hanker, L.
    Rody, A.
    Buendgen, N.
    Banys-Paluchowski, M.
    ONKOLOGIE, 2023, 29 (02): : 157 - 159
  • [48] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
    Luciana de Moura Leite
    Marcelle Goldner Cesca
    Monique Celeste Tavares
    Debora Maciel Santana
    Erick Figueiredo Saldanha
    Paula Tavares Guimarães
    Daniella Dias Silva Sá
    Maria Fernanda Evangelista Simões
    Rafael Lima Viana
    Francisca Giselle Rocha
    Simone Klog Loose
    Sinara Figueiredo Silva
    Rafaela Pirolli
    Camilla Albina Zanco Fogassa
    Bruna Raphaeli Silva Mattos
    Fernando Augusto Batista Campos
    Solange Moraes Sanches
    Vladmir Cláudio Cordeiro de Lima
    Noam Falbel Pondé
    Breast Cancer Research and Treatment, 2021, 190 : 155 - 163
  • [49] Assessment of HER2-Low Status in HER2-Mutant Breast Carcinoma
    Yang, Ellen
    Pareja, Fresia
    Rana, Satshil
    Brannon, A.
    Vanderbilt, Chad
    Dikoglu, Esra
    Grabenstetter, Anne
    Wen, Hannah
    Brogi, Edi
    Ross, Dara
    LABORATORY INVESTIGATION, 2024, 104 (03) : S313 - S315
  • [50] Prognostic value of HER2-low status in breast cancer: A systematic review and metaanalysis
    Molinelli, Chiara
    Jacobs, Flavia
    Agostinetto, Elisa
    Marta, Guilherme Nader
    Ceppi, Marcello
    Bruzzone, Marco
    Blondeaux, Eva
    Schettini, Francesco
    Prat, Aleix
    Viale, Giuseppe
    Del Mastro, Lucia
    Lambertini, Matteo
    de Azambuja, Evandro
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345